Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Thanarajasingam

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Neuroimmunology|November 23, 2024
Pre-existing Lambert-Eaton Myasthenic Syndrome and Scleroderma in a Patient with Neuroendocrine Carcinoma Undergoing Immune Checkpoint Inhibitor Cancer ImmunotherapyNisa Vorasoot, Thorvardur R Halfdanarson, Nicolas N Madigan, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 12, 2021
Clinical Presentations and Outcomes of Patients Receiving Immune Checkpoint Inhibitors Presenting to the Emergency DepartmentRichmond M Castillo, Benjamin J Sandefur, Alexander S Finch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapyMichael Gough, Marka Crittenden, Uma Thanarajasingam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2018
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One PatientsMichael D Richter, Cynthia Crowson, Lisa A Kottschade, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2018
Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic ExperienceMichael D Richter, Olga Pinkston, Lisa A Kottschade, et al.
Mayo Clinic Proceedings|June 11, 2017
Scleroderma Induced by Pembrolizumab: A Case SeriesNaiara S Barbosa, David A Wetter, Carilyn N Wieland, et al.
Cancer Research|January 11, 2007
Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapyUma Thanarajasingam, Laura Sanz, Rosa Diaz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2019
MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum settingPhilippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, et al.
Clinical Rheumatology|May 31, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritisYuan Liu, Jane M Jaquith, Kathleen Mccarthy-Fruin, et al.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|November 23, 2024
Pre-existing Lambert-Eaton Myasthenic Syndrome and Scleroderma in a Patient with Neuroendocrine Carcinoma Undergoing Immune Checkpoint Inhibitor Cancer ImmunotherapyNisa Vorasoot, Thorvardur R Halfdanarson, Nicolas N Madigan, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|November 12, 2021
Clinical Presentations and Outcomes of Patients Receiving Immune Checkpoint Inhibitors Presenting to the Emergency DepartmentRichmond M Castillo, Benjamin J Sandefur, Alexander S Finch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapyMichael Gough, Marka Crittenden, Uma Thanarajasingam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2018
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One PatientsMichael D Richter, Cynthia Crowson, Lisa A Kottschade, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2018
Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic ExperienceMichael D Richter, Olga Pinkston, Lisa A Kottschade, et al.
Mayo Clinic Proceedings|June 11, 2017
Scleroderma Induced by Pembrolizumab: A Case SeriesNaiara S Barbosa, David A Wetter, Carilyn N Wieland, et al.
Cancer Research|January 11, 2007
Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapyUma Thanarajasingam, Laura Sanz, Rosa Diaz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2019
MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum settingPhilippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, et al.
Clinical Rheumatology|May 31, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritisYuan Liu, Jane M Jaquith, Kathleen Mccarthy-Fruin, et al.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Pageof 4